Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
MYLAN DIAZEPAM APPROVAL WAS DELAYED BY FDA SO THAT SIMULTANEOUS APPROVALS COULD BE GRANTED, MYLAN CONTENDS; BARR LABS, BARRE NATIONAL TESTIFY ALSO
May 15 1989
Â
•Â
ByÂ
The Pink Sheet
 Â
More from Archive
More from Pink Sheet